Alternate day ganciclovir and foscarnet is safe and effective in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients
Year: 2006
Type: article
Institutions: Morgan Stanley Children's Hospital, Columbia University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W1967830696
